NKTR 8-K 2026-10-01

NEKTAR THERAPEUTICS (NKTR) 8-K dated 2026-10-01 — accession 0001213900-26-105453. This URL is the filing, not the NKTR hub.

NEKTAR THERAPEUTICS (NKTR) is a biotechnology company listed on US.

NEKTAR THERAPEUTICS filed a 8-K on 2026-10-01. Accession 0001213900-26-105453.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NKTR revenue for 2025-12-31 was $55.2M. Net income was -$164.1M. Revenue was down 43.9% from 2024-12-31 to 2025-12-31. NKTR currently screens at market cap $307.2M.

Not investment advice. The NKTR SEC hub lists recent forms. The stock page is the research view.